drug · antibody
patient view →anifrolumab
Phase 3updated 2mo agoby $AZN ASTRAZENECA PLC🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for systemic lupus erythematosus and 7 investigational indications.
indications
indications
Lupus
targets
Interferon alpha/beta receptor 1
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that